Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus RNA codes for proteins and replicates: does it also trigger the interferon response?

A D Branch1

  • 1Department of Medicine, Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, New York 10029, USA. ab8@doc.mssm.edu

Seminars in Liver Disease
|July 15, 2000
PubMed
Summary

Hepatitis C virus (HCV) RNA replication is an error-prone process generating diverse quasispecies. This viral RNA plasticity and immune evasion mechanisms contribute to persistent HCV infections, despite innate immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens.

Journal of viral hepatitis·2016
Same author

Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.

Transplant infectious disease : an official journal of the Transplantation Society·2015
Same author

Commentary: real-world triple therapy experience treating hepatitis C virus - authors' reply.

Alimentary pharmacology & therapeutics·2014
Same author

Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir.

Alimentary pharmacology & therapeutics·2013
Same author

The coming impact of gene expression profiling on the diagnosis and treatment of HCV-associated liver disease.

Antiviral research·2001
Same author

Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame.

RNA (New York, N.Y.)·2001

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Hepatitis C virus (HCV) possesses a positive-sense genomic RNA crucial for its replication and gene expression.
  • Conserved regions, particularly the 5' and 3' non-translated regions (NTRs), contain essential signals for viral processes.
  • The 5'NTR features an internal ribosome entry site (IRES) critical for initiating protein synthesis.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying Hepatitis C virus (HCV) RNA replication and its interaction with the host immune system.
  • To understand the genetic diversity generated during HCV replication and its implications for viral evolution and persistence.
  • To explore potential therapeutic targets based on HCV RNA structure and replication processes.

Main Methods:

Related Experiment Videos

  • Analysis of HCV genomic RNA structure, including conserved non-translated regions (NTRs) and the internal ribosome entry site (IRES).
  • Investigation of the viral RNA replication cycle, involving complementary antigenomic RNA synthesis and progeny RNA production.
  • Examination of the interplay between HCV RNA, particularly double-stranded RNA intermediates, and the host innate immune response (interferon induction).

Main Results:

  • HCV RNA replication is an error-prone process, leading to the generation of diverse RNA quasispecies through mutation and natural selection.
  • Conserved 5' and 3' NTRs play critical roles in replication and translation efficiency.
  • HCV-specific double-stranded RNA can induce innate immunity, but the virus often evades immune clearance through genome plasticity and low gene expression.

Conclusions:

  • The genetic plasticity of HCV RNA contributes to viral evolution and the development of varied genotypes.
  • HCV's ability to evade immune responses is linked to its genome's characteristics and gene expression levels.
  • Therapeutic strategies targeting HCV RNA, such as antisense drugs and ribozymes, show promise for future interventions.